Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones02:11 · Ratings

Aptose Biosciences Analyst Ratings

Benzinga01:59 · Ratings

Canada Net Change Percentage Gainers & Losers

Dow Jones01:31

Express News | Aptose Biosciences Inc : H.c. Wainwright Cuts Target Price to $2 From $7

BreakingsNov 20 22:58

Aptose Biosciences Down 5% in U.S. Premarket, Initiates Study for Newly Diagnosed AML Patients

MT NewswiresNov 20 21:31

Aptose Biosciences Brief: Initiating Study for Newly Diagnosed AML Patients to Receive Tuspetinib-based Triplet Therapy

MT NewswiresNov 20 20:32